Letter: tacrolimus may be hazardous in decompensated autoimmune liver disease with hyperbilirubinemia—authors’ reply
Ynto S. de Boer(Amsterdam University Medical Centers), Michael A. Heneghan(King's College Hospital NHS Foundation Trust), Rodrigo Liberal(King's College - North Carolina)
Cited by 0
Related Papers
Autoimmune hepatitis
|The Lancet|2013|280
Autoimmune hepatitis (AIH) in the elderly: A systematic retrospective analysis of a large group of consecutive patients with definite AIH followed at a tertiary referral centre
|Journal of Hepatology|2006|208
Dysfunctional CD39POS regulatory T cells and aberrant control of T-helper type 17 cells in autoimmune hepatitis
|Hepatology|2013|187